http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34601159

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 289
issn 1179-1322
pageRange 277-289
publicationName Cancer Management and Research
startingPage 277
bibliographicCitation Liu X, Ma X, Ou K, Wang Q, Gao L, Yang L. Real-World Results of Raltitrexed Combined with S-1 and Bevacizumab in Heavily Pretreated Metastatic Colorectal Cancer. Cancer Manag Res. 2023;15():277–89. PMID: 36969545; PMCID: PMC10038009.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2762-6719
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3cc1c482fcffd13fca927b9fb138bd28
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c353b3889221503093deb118d75a9281
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f749cfdca0d90dd1b6d4e4932dc98ecc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1329-9761
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fd57a39e61ebfcc51521535235a2c200
date 202303
identifier https://doi.org/10.2147/cmar.s398539
https://pubmed.ncbi.nlm.nih.gov/PMC10038009
https://pubmed.ncbi.nlm.nih.gov/36969545
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/36231
https://portal.issn.org/resource/ISSN/1179-1322
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Real-World Results of Raltitrexed Combined with S-1 and Bevacizumab in Heavily Pretreated Metastatic Colorectal Cancer
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135400182
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_714b3f52d8149c3277181d9513b93112
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9672

Total number of triples: 27.